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ABSTRACT 
Virechana Karma is one of the prime modality of the treatment in Panchakarma. Different types and forms 
of Virechana Yoga’s are mentioned with specific indications in classics. The trail drug Trivrt Ashtaka 
Churna is one of the such Virechana Yoga told in our classic. Clinical validation of this drug is further 
requires, scientific explanation and justification for its global acceptance as a Virechaka Yoga. Tamaka 
Shwasa occurs mainly due to vitiation Kapha Vata Dosha’s in Pitta Sthana. It shows close resemblance with 
Bronchial Asthma on the basis of clinical manifestations. Managing Bronchial asthma on Ayurvedic line of 
treatment is totally different from that of conventional management. Virechana Karma is the best modality 
in management of Tamaka Shwasa. Hence the present study has been taken up to see the efficacy of trail 
drug Trivrt Ashtaka Churna on 30 cases of Tamaka Shwasa (Bronchial Asthma). Results: The study 
observations showed that the100% good palatability for Virechana Yoga, 64.3% patients got their first 
Vega on an average time 30 minutes, in 57.1% patients 16 - 18 Vegas were noted, Samyak Shuddi Lakshana 
with Pittanta was observed in 57.1% of patients.There was a highly significant improvement in symptoms 
like Swasa krichrata, Kasa, Ghurghuraka, Kaphanishtivana and in signs like Ronchi, Wheeze and 
Respiration rate got highly significant results (at p<0.001). Conclusion: After going through the clinical 
changes observed during and after the treatment, it may be opined that, Trivrt Ashtaka Churna acts as a 
Virechaka Yoga significantly in the management of signs and symptoms of Tamaka Shwasa. 
KEYWORDS: Tamaka Shwasa, Bronchial Asthma, Trivrt Ashtaka Churna, Virechana Karma. 
INTRODUCTION
 Tamaka Shwasa is a Pranavaha Srotovikara1. 
Being Kapha-Vata dominant disease, it takes its origin 
from Pittastana2. Any illness in a person enforces him to be 
restricted to bed is the usual consequence but in this 
disease patient gets up instead of lying on the bed which is 
the most comfortable position for Shwasa-Rogi. Tamaka 
Shwasa is mentioned as one of the variety among five 
types of Shwasa. It is a 'Swantartra' Vyadhi and having its 
own aetiology, pathology and management. It is mentioned 
as Yapya Vyadhi i.e. chronic in nature. 
 Bronchial Asthma closely resembles with Tamaka 
Shwasasymptoms3. Asthma is a serious condition which 
can directly hamper the one’s ability to breathe and 
suddenly deprive the most important nutrient of life i.e. 
Oxygen. People who are having an Asthma attack have real 
trouble in taking a breath. Many people with stuffy filled 
noses due to hay fever or colds say, "I can't breathe" but 
they retain the option of breathing through the mouth. 
However, in Asthmatics they known what "I can't breathe" 
actually means, as in here, instead of their nasal passages, 
it is the bronchial tubes in their lungs that become swollen 
and clogged. Breathing can become frighteningly difficult4. 
Asthma involves two conditions:  
(1) Contraction of the small muscles surrounding the 
bronchial tubes and 
(2) Inflammation of the lining of those tubes. 
 The global prevalence of asthma is anticipated to 
be approximately 4.5 percent5,6. There are about 334 
million patients with asthma affecting all age groups, 
across the world7 and its present mortality rate is yearly 
5000 deaths in 10million of people. A recent analysis using 
three different estimate models (INSEARCH, GINA and 
WHO survey) suggests that the prevalence of asthma in 
India varies between 2.05 to 3.5 per cent (17-30 million 
patients)8.  
 The estimated cost of asthma treatment per year 
for the year 2015 has been calculated to be approximately 
`139.45 billion9, in India. An estimated 15 million disability 
adjusted life years (DALYs) are lost due to asthma5,10.  
 In present scenario Panchakarma (Detoxification) 
therapy is the best way to effectively & safely manage 
these conditions without any drug dependency. Here the 
medicated Gritha is used which gives nutrition & increases 
the elasticity of lung tissue & develops natural immunity of 
the body.  
 Shodhana procedure has given a due importance 
in this disease by almost all Acharyas. So keeping this point 
in mind, only Shodhana therapy is considered as 
therapeutic regime in this study. This study has been 
designed to assess the efficacy of trial drug “Trivrt Ashtaka 
Churna”11 as a Virechaka Yoga in the management of 
Tamaka-Shwasa. 
 In the management of Tamaka Shwasa, 
Samshodhana has a got vital role were in excessively 
vitiated Doshas are eliminated from their abode. Acharya 
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Charaka mentioned “Vata Shleshma Haraihi Yuktam 
Tamaketu Virechanam”12, Virechana Karma in the 
Management of Tamaka Shwasa as it acts not only on Pitta 
Dosha but also on Vata and Kapha Dosha13. So here in the 
present study Snehapana with Kantakari gritha14, Swedana 
and Virechana with trail drug Trivrt Ashtaka Churna is 
considered. 
AIMS AND OBJECTIVES 
1. To evaluate the effect of Trivrt Ashtaka Churna as 
Virechaka Yoga in management of Tamaka Shwasa 
(Bronchial Asthma). 
2. To evaluate the effect of Virechana Karma on signs 
and symptoms of Tamaka Shwasa (Bronchial 
Asthma). 
MATERIALS & METHODS 
Selection of the patients: 30 patients diagnosed with 
Tamaka Shwasa (Bronchial Asthma) were taken for study 
from IPD of S.D.M college of Ayurveda and Hospital, 
Hassan, Karnataka. 
Source of Drugs: The required raw drug for the treatment 
was purchased in SDM Ayurvedic pharmacy, Hassan. 
Method of collection of data: The patients were selected 
randomly irrespective of caste, religion and locality. A 
special proforma was prepared with all points of history 
taking, symptom as quoted in Ayurvedic literatures. The 
selected patients were subjected to detail clinical history 
and complete physical examination before undergoing the 
clinical study. 
Criteria for diagnosis 
1. As per classical signs & symptoms of the disease. 
2. By detailed case taking using the proforma.  
 Before administration of therapy, a detailed 
proforma containing complete history, Signs & symptoms, 
Dasha vidha Pariksha, Nidana Panchaka etc. from classics 
are compiled & filled for each patient. 
 Apart from these Respiratory system 
examinations with regards to Inspection, palpation, 
Percussion & auscultation were done; certain vital data’s 
B.P, pulse, Respiratory rate, Temperature were also 
monitored. 
 Along with this Spirometry test, Hb%, TC, DC, ESR 
were done for all the patients in before treatment & after 
follow up Spirometry test was done to see the change. 
 RBS, urine analysis, ECG, X-ray & other relevant 
investigations were also carried out before starting the 
treatment. All these were carried out in the laboratory of 
S.D.M. Ayurveda Hospital, Hassan.  
 Some of these investigations were carried out in 2 
sittings, during pre and post therapeutic measures, to 
know the efficacy of the treatment on these parameters. 
Finally, the obtained results will be represented with the 
aid of analytical Statistical techniques. 
Inclusion Criteria 
1. Mild intermittent, mild persistent, moderate 
persistent asthma according to Global Initiative for 
Asthma (GINA) guideline.15 
2. Patients in the age group of 17 to 65 years either of 
sex.  
3. Patients who are in fit for Virechana Karma. 
Exclusion Criteria 
1. Severe persistent asthma according to Global 
Initiative for Asthma (GINA) guideline16. 
2. Patient who are unfit for Virechana Karma. 
3. Patient of Tamaka Shwasa with any complication and 
systemic disorders. 
4. Patient of Tamaka Shwasa with Chronic Bronchitis, 
Pulmonary Tuberculosis. 
Drug, Dose & Durations of therapy 
 Initially Koshta Pariksha was done using Triphala 
Churna 1tsp with warm water or 1 cup of Sugarcane juice 
or 1 cup of warm Milk, etc. at bed time. According to Mala 
Pravriti which was observed next day Koshta was decided. 
As the all patients had Madyama Koshta, so the dose of 
Virechana yoga (Trivrt Ashtaka Churna) was fixed to 
Madhyama Churna Yoga Matra i.e. 2 Karsha (as a whole 30 
grams)17. 
Design of group and management 
Study is divided into 3 main parts i.e.  
1. Purvakarma 
2. Pradhanakarma 
3. Paschatkarma 
Purvakarma 
Deepana-Pachana: Panchakola Phanta 30ml thrice a day 
before food was given till the attainment of Nirama 
Lakshanas was given. 
Snehapana: Kantakari Ghrita was given in Arohana karma 
depending on the Agni until the Samyak Snigdha Lakshanas 
were achieved. 
Vishrama Kala: Sarvanga Abhyanga with Murchita Taila 
for 35 minutes followed by Mrudu Bhashpa Sweda 
Dashamula Kwatha was given and advice to take Ushna 
Jala Snana consequently for 3 days. 
Pradhana Karma 
 On the day of Virechana Sarvanga Abhyanga with 
Murchita Taila for 35 minutes followed by Mrudu Bhashpa 
Sweda with Dashamula kwatha was given. Trivrit Ashtaka 
Churna as Virechaka Yoga was administered in the dose of 
30 gm between 8:50am to 9:15am with Madhu as Anupana. 
Paschatkarma 
Patient was kept on Samsarjana Krama according to 
Shuddhi attained. 
Abhyantara Snehapana 
 Snehapana was done in Arohana Karma with the 
initial dose fixed at 30ml which was later increased day by 
day by 30-70ml looking in to time taken to digest Sneha on 
day to day basis till Samyak Snigdha Lakshanas were 
observed. Kantakari Gritha was administrated early in the 
morning with Ushna Jala as a Anupana. Finally, the 
appearances of Samyak Snigdha Lakhanas were considered 
as the final criteria to stop Snehapana. Diet during 
Snehapana was considered according to the rule of 
Snehapana. i.e. Drava, Ushna, Anabhishyandhi, 
Pramanathah (in proper quantity), Naatisnigdha, 
Asankirna-Ahara was given.  
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Virechana Karma 
 After Samyak Snigdha Lakshana appeared, 3 days 
of gap was given were in Abyanga with Murchita Taila 
followed by Bashpa Sweda with Dashamoola Kashaya were 
performed. On the day of Virechana after evacuation of 
natural urges & bath, in empty stomach again Bahya 
Abyanga followed by Bashpa Sweda is to be administered. 
After passing of Kapha Kala i.e. at about 8:50am to 
9:15am.Patient was administered with Trivrit Ashtaka 
Churna as a Virechaka Yoga was administered in the dose 
of 30gm with Madhu as Anupana. All the vitals like Blood 
pressure, Pulse and Respiration rate are noted. These 
vitals are also recorded during the complete process of 
Virechana Karma. Care full observation is done for 
assessing the Virechana Vegas and the patient is advised to 
observe the color of stool, smell, type of excreted 
materials, its constitutions, Snigdhata, any burning 
sensation, pain, till the Kaphanta Virechana conditions 
arises. At last, the patient is assessed for type of Shudhi, 
Hina, Madhyama, and Uttama. 
Samsarjana Krama 
 Depending on the Shuddhi Lakshanas Samsarjana 
Krama was started with Peya, Vilepi, Akrita & Krita Yusha, 
Akrita & Krita Mamsa Rasa for 3, 2 & 1 Anna Kala 
respectively in Pravara, Madhyama & Avara shuddhis.  
Criteria to assess the Signs & Symptoms 
 The chief criteria was the relief in clinical signs & 
symptoms. These were assessed by giving specific scores 
which were helpful in Statistical analysis. These scores are 
presented as follows.  
1. After Snehapana: for Samyak Snigdha Lakshanas 
2. After Virechana Karma 
a. Drug palatability 
b. Time taken for the onset of Virechana  
c. Number of Virechana Vega 
d. Duration of Virechana  
e. Anthiki Shuddhi 
f. Laingiki Shuddhi 
g. Vegiki Shuddhi 
h. Virechana Vyapad (if any) 
i. Discomfort to the patient 
j. Respiration, Pulse rate and Blood pressure before, 
during and after Virechana Karma. 
3. Severity of Tamaka Shwasa 
1.Mild intermittent 
 Symptoms-symptoms <2 times a week. 
 Asymptomatic and normal PEF between 
exacerbations, brief exacerbation (few hours too few 
days), and intensity may vary. 
 Night time symptoms < 2 times a month. 
 Lung function – FEV, or PEF 60% to 80% predicted, 
PEF variability>20% 
2. Mild persistent 
 Symptoms- symptoms > 2 times a week but < 1 time a 
day, exacerbation may affect activity. 
 Night time symptoms > 2 times a month 
 Lung function - FEV, or PEF 80% predicted PEF 
variability 20% to 30%. 
3. Moderate persistent 
 Symptoms - Daily symptoms, daily use of inhaled 
short acting beta2 agonist, exacerbations affect 
activity, exacerbations>2 times a week, may last for 
few days. 
 Lung Functions - FEV or PEV 60% to 80% predicted, 
PEF variability > 30%. 
4. Severe Persistent 
 Continual symptoms, limited. 
 Physical activity affected with frequent 
exacerbation. 
 Night time symptoms – frequent. 
 Lung function - PEV or PEF < 60% of predicted, PEF 
variability > 30% 
4. Vyadhi Pradhana Lakshana with Avadhi 
1. Shvasakrichatha (Difficulty in breathing)  
1- Mild - Breathlessness with activity  
2- Moderate - With talking. 
3- Severe - At rest. 
4-Impending respiratory failure Breathlessness at 
rest. 
2. Shvasakrichatha with Duration 
0‐ No attack 
1‐ once in a month 
2‐ once in two week 
3‐ once a week 
4‐ twise a week 
5‐ everyday  
3. Kasa (coughing) severity 
0‐ no cough 
1‐ occ. Cough 
2‐ cough at night 
3‐ throughout day time 
4‐ throughout day & night 
4. Ghurghurukam (audible wheez) 
0‐ no Ghurghurukam (wheezing) 
1‐ Ghurghurukam (wheezing) only during attack 
2‐ very often Ghurghuruk (wheezing) sound 
3- Ghurghurukam (wheezing) at night 
4‐ Ghurghurukam (wheezing) all the time 
5. Parshvashula (pain in intercostals space, 
thoracic region) 
0‐ no pain 
1‐ pain on exertion 
2‐ pain on cough 
3‐ pain relieved by expectoration 
4‐ pain during attack of breathlessness 
6. Asino Labhatesaukhyam (get relief with sitting 
posture) 
0‐ can sleep easily 
1‐ can sleep with Head end Elevation 
2‐ cantsleep,spontaneous sitting upright 
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7. Kapha Nishthivan (sputum) 
0‐ No Kaphanishthivana 
1‐ occ. Sputum 
2‐ only in morning 
3‐ only in night 
4‐ through out day 
5. Spirometry tests 
Computerized electronic kit micro spirometer was used in 
this study for assessing pulmonary ventilation capacity. 
The technical features of this spirometer included-  
 Flow meter  Bi-directional digital turbine.  
 Range for flow measurement 0.03 - 20 l/s 
 Range for volume measurement  10l  
 Accuracy of measurement   3% or 50 ml  
 Dynamic Resistance @ 12 l/s  < 0.7 cmH2O/l/s 
 The interpretation of the predicted values for 
Spirometric Lung volumes was calculated following the 
ERS 93 criteria (Official Statement of the European 
Respiratory Society, The European Respiratory Journal 
Volume 6, Supplement 16, and March 1993.) following is 
the list of Spirometric tests, included in the present study 
on Tamaka Shwasa. 
SymbolUM Parameter 
FVC l (btps) Forced Expiratory Vital Capacity 
FEV1 l (btps)
  
Forced Expiratory Volume in 1 
second 
PEF l/sec Peak Expiratory Flow 
FEV1/FVC% FEV1 as a percentage of FVC  
STASTICAL ANALYSIS 
Statistical package for social science (SPSS) version 20 was 
used for the data analysis.  
• Friedman’s test.  
• Post Hoc analysis with Wilcoxin signed rank test 
with Bonferroni correction applied. 
• Paired ‘t’ test. 
• Cochran’s Q test. 
OBSERVATIONS 
Observations on Patient 
 In this study among 30 patients 28 completed the 
whole treatment course, as 2 patients left the treatment 
due to their personal problems. So among 28 patients, 
maximum i.e. 35.7% were in age group of 21 to 30 years, 
there were 42.9% of male and 57.1% of female patients, 
maximum numbers of patients (96.4%) were Hindus, 
64.3% patients are from Urban habitat, maximum 46.4% 
(each) patients were students, majority of 57.1% of patient 
were belonging to middle class, maximum number of 
patients 53.6% have studied up to Pre University level, 
maximum numbers of patients i.e. 53.6% were bachelors, 
78.6% of patients were having Moderate Shwasakrichrata, 
42.9% of patients were having Shwasakrichrata once in 
two weeks, 35.7% patients were having Kasa at night, 
39.6% of patients were complaining of Wheezing during 
attack, 50% of patients were complaining of Pain on 
Cough, 75% were able to sleep with Head end elevation, 
46.4% were having Kaphanishtivana only in morning time, 
60.7% of lies were having Moderate Persistent Asthma, 
71.4% patients had Gradual onset of disease, 85.7% of 
patients the course of disease was relapsing, aggravating 
season for the maximum number of patients i.e. 46.4% was 
in winter season, 50% of patients got relief after exposure 
to hot environment, 50% of patients got relief after 
exposure to hot environment, 50% had disease onset 
between 2.1-5 years, 46.4% of patients had no family 
history of Tamaka Shwasa, 46.4% of patients took 
Expectorants, 78.6% are consuming Non-vegetarian foods, 
60.7% had Vishamasana, 42.9% were studying, 60.7% 
patients reported disturbed sleep, 60.7% were having 
normal consistency of Bowel, 78.6% were addicted to 
Coffee/Tea as a daily habit, 50% were having Kapha 
Prakruti, 70% of patient were having Pravara Satva, 60% 
of patients were of Madhyama Satmya, 43.30% were 
having Madhyama Vyayamashakti. 
Observations on Treatment 
 During treatment, among 28 patients, 46.4% of 
patients took 2 days for Deepana and Pachana, 60.7% 
patients took Snehapana for 4 days, all patients had 
showed that Virechana Yoga is 100% palatable, 64.3% 
patients had 1st Virechana Vega less than half an hour, 
46.4% patients had completed Virechana in 7.30 to 9.00 
hours, 57.1% patients got 15 to 19 Vegas, 89.3% got 
Madhyama Vegiki Shuddhi Lakshanas, 57.1% got Pittanta. 
 Among Virechana Samyak Yoga Lakshana’s, 
Agnivriddhi (100%), Kshudha Pravrutti (90%), Trishna 
Pravrutti (96.4%), Srotovishuddhi (96.4%) & Indriya 
Prasada (92.8%), Laghuta (100%), Vatanulomana (100%), 
Daurbalyata (76%), Vit-Pitta-Kapha-Vata Kramena Prapti 
(79.2%), and Manah Prasada (47%) were observed. 92.9% 
patients had completed Madhyama Shuddhi Samsarjana 
Krama.  
RESULTS 
Table 1: Subjective Parameters of Tamaka Shwasa 
Serial No. Parameter Chi-Square P value Remark  
1 Shwasakrichrata 61.024 < 0.001 S 
2 Duration of Shwasakrichrata 67.452 < 0.001 S 
3 Severity of Kasa 42.339 < 0.001 S 
4 Ghurghuraka 51.691 < 0.001 S 
5 Parshvashula 48.724 < 0.001 S 
6 Aasinolabhatesaukhyam 32.609 < 0.001 S 
7 Kaphanishtivana 46.701 < 0.001 S 
 Int. J. Ayur. Pharma Research, 2016;4(7):43-52  
 IJAPR | July 2016 | Vol 4 | Issue 7   47 
 To know the effect Virechana on Subjective Parameters of Tamaka Shwasa like Shwasakrichrata, duration of 
Shwasakrichrata, Kasa, Ghurghuraka, Parshvashula, Aasinolabhatesaukhyam and Kaphanishtivana, first Friedman test was 
applied and here in all parameters it shows that there were statistically significant differences are found with respective to 
X2and p < 0.001 values. Post hoc analysis with Wilcoxon signed rank tests was conducted with a Bonferroni correction 
applied, resulting in a significant level set at 0.0125 (Table.1) 
Table 2: Results on Objective Parameters 
Serial No. Parameter Chi-Square P value Remark  
1 Breath sounds 58.395 < 0.001 S 
2 Adventitious sounds 42.284 < 0.001 S 
3 Ronchi sounds 8.214 < 0.001 S 
4 Crepitation sounds 5.00 0.172 NS 
 To know the effect Virechana on Objective Parameters like Breath sounds, Adventitious sounds, Ronchi sounds 
and Crepitation sounds, first Friedman test was applied and here in all parameters except Crepitation sounds, shows that 
there were statistically significant differences are found with respective to X2and p < 0.001 values. Post hoc analysis with 
Wilcoxon signed rank tests was conducted with a Bonferroni correction applied, resulting in a significant level set at 
0.0125 (Table.2). 
Table 3: The results of Student ‘t’ test on Spirometry Analysis 
Parameters of Spirometry 
(analysed Before Treatment - After 
Samsarjana Krama) 
Mean SD  SE t Value p Value 
Sig. (2-tailed) 
 Interpretation 
FVC 
Forced Vital Capacity 
-25.714 33.92 6.411 -4.011 < 0.001 S 
FEV1 
Forced Expiration Volume in 1 sec 
-17.429 31.97 6.042 -2.885 0.008 S 
FEV1/FVC% 
FEV1 as % of FVC 
1.321 15.149 2.863 0.462 0.648 NS 
Respiratory Rate  2.786 1.572 0.297 9.378 < 0.001 S 
To know the effect of treatment on parameters of Spirometry, paired t-test was applied. It is evident from the above table 
that there was significant change FVC and FEV1 at all the levels of the treatment with p<0.001, but non-significant in 
FEV1/FVC at the all levels of the treatment with p = 0.648 (Table.3) 
To know the effect of treatment on Respiratory rate, paired t-test was applied. It is evident from the above table that there 
was significant change in Respiratory rate at all the levels of the treatment with p<0.001 (Table.3) 
Results of Cochran’s test on Virechana Samyaka Yoga Lakshana 
Graph.1: Results on Subjective Parameters of Virechana 
 
Cochran’s Q test analysis where Q=159.84 and p < 0.001 found significant results in Samyak Virikta Lakshanas, this shows 
that 30 gms of Trivrt Ashtaka Churna can produce Samyaka Yoga Lakshana in Mrudhu Koshta individuals. (Graph.1) 
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Graph 2: Results of Cochran’s test on Virechana Ayoga Lakshana 
 
Among Virechana Ayoga Lakshanas Chardi in 16 patients and Tandra in 5 patients were observed and further these 
symptoms were subsided by itself (Graph.2) 
DISCUSSION 
The Disease 
 Tamaka Shwasais explained in all Samhita which 
shows the existence of the disease from ancient time. 
Almost all the classics related to the Ayurveda have 
explained about Pancha Shwasa, and Acharya Charaka has 
explained separate Samprapti for Tamaka Shwasa apart 
from general Samprapti of Shwasa and the treatment 
explained in Shwasa Chikitsa Adhikara is primarily for 
Tamaka Shwasa only. 
 This disease is having very close resemblance with 
Bronchial Asthma. Hypersensitivity of the tracheao-
bronchial tree to a number of allergens is said to be the 
basic pathology of Bronchial asthma in modern parlance. 
This hypersensitivity reaction results in inflammation of 
the air passages. The inflammation is characterized by 
wide spread congestion of the tracheao-bronchial tree, 
spasm of the smooth muscle and secretion of tenacious 
sputum. These pathological changes contribute to the 
narrowing of the air passages. Thus the patient develops 
the difficulty in breathing. Personal or family history of 
respiratory or skin allergy, positive wheal and flare skin 
reaction test and increased level of the IgE 
immunoglobulin are all suggestive of Allergic asthma. 
Absence of these phenomena is indicative of idiosyncratic 
type of Bronchial-Asthma. Moderate eosinophilia and 
abnormal lung volumes which is assessed by the 
Spirometer are the other manifestations of the illness. The 
present medicines like Broncho dilators, Cortico steroids, 
antihistamine etc. are only symptomatic remedies till there 
is no complete curable treatment for Bronchial Asthma. 
 The global prevalence of asthma is anticipated to 
be approximately 4.5 percent. In India, the prevalence of 
asthma in adults was 2.05 per cent, with an estimated 
burden of 17.23 million.  
 Physicians across India depend primarily on the 
International guidelines like the GINA guidelines to 
manage patients with asthma. Although the international 
guidelines are evidence-based, it is important to realize 
that these may not be applicable to our population. 
 The main aetiopathogenosis of Tamaka Shwasa is 
based on provocation of Vata Dosha and obstruction to 
Pranavaha Srotas due to vitiated Kapha. The vitiation of 
Pittastana effects the normal function of Pitta and give rise 
to Ama formation. Thus improper digestion will lead to 
faulty production of Annarasa and Malarupa Kapha. Hence 
Ama Rasa formed in Amashaya may further vitiate the 
Pranavaha Srotas. In the above mode of vitiation Prana, 
Anna, Udakavaha Srotas will vitiate. The vitiation of Kapha 
will produce localized edema, excessive recurrent mucoid 
sputum, hypertrophy of bronchial musculature, loss of 
appetite, anorexia etc. Whereas vitiation of Vata leads to 
spasm of diaphragm, inspiratory muscles, smooth muscles 
of bronchial wall etc., which in turn lead to difficulty in 
breathing. 
The Virechana Karma 
Pachana: Before the administration of Snehapana, the 
body should have Nirama state which is achieved by 
Pachana and Agni Vriddhi achieved by Deepana state. The 
reason behind it is that the qualities of Snehana Dravya 
need a platform for its action. These drugs which are 
digestive and carminatives stimulate enzymes, HCL, 
pancreatic and bile secretions thereby proper assimilation 
of Snehana occurs. 
Snehana: Snehapana plays a vital role in any Shodhana 
Karma. Doshas which are lodged in Shakha are made to 
move towards Koshta by means of oleation and 
fomentation. Sneha is able to increase the quantity of 
Dosha (Utklesha) at the site of disease due to Kledana 
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property. It loosens and softens the Dosha, increases the 
liquidity, directs the Dosha towards Koshta, it can enter 
into minute channels and remove Dosha. Thus it helps in 
Bringing the Dosha from periphery (Shakha) to Koshta. If 
Snehapana is not done and Virechana is carried out, then it 
destroys the tissues of the body. 
Swedana: It provides kinetic energy by Ushna Guna to 
those Doshas which are ready to leave from their site of 
adhesion to the nearest site of elimination. Hence 
combined action of Snehana and Swedana makes the 
detachment from the Shakha and helps to move towards 
Koshta for easy evacuation. Due to production of heat the 
toxic metabolites are carried by the blood and are brought 
to the Koshta. 
Vishrama Kala: After completion of Snehapana 3 day’s 
gap is kept for Abhyanga and Swedana, this three days gap 
is kept to bring Manda Kapha stage, which is necessary for 
Samyak Virechana. 
Virechana Karma: Although, the Virechana is considered 
the prime treatment modality for Pitta Dosha, it is used in 
the conditions involving the disorders in which the Pitta is 
associated with Kapha or Vata. It has direct four criteria 
are mentioned for the assessment of Samyak Virechanai.e. 
Vegiki, Maniki, Laingiki and Antiki. Among these Laingiki 
criteria must be considered mainly for deciding the 
Samsarjana Krama. Antiki criteria are indicated to stop the 
process of Virechana. The Virechana drug should be 
administered after the Shleshma Kala has been passed.  
Samsarjana Krama: After evacuation, the status of the 
Agni will get reduced so one should take Peya, Vilepi, 
Akruta and Kruta Yusha Rasa, in three, two or one meal 
time according to the evacuation. As little fire kindled 
gradually with grasses, cow dung etc. Becomes great, 
stable and all-digesting.  
The Drug 
 Trivrt is best among all Virechaka dravyas & is 
known as the Sukha Virechaka & Kapha-Vatahara in 
nature. Similarly, Sarkar is Vata-Pittahara and other drugs 
like Mustha, Vidanga, Trikatu, Trijataka are Vata-Kapha 
hara Vataanulomaka. Amalaki acts as Rasayana, 
Tridoshagna and Haritaki acts as Tridoshagna, 
Vataanulomaka. So the combination of all these drugs 
behaves as Tridoshaghana. In Tamaka Shwasa Kapha & 
Vata are the predominant Doshas & Pitta is the origin site 
of the disease. So this Trivrt Ashtaka Churna is an ideal 
combination which acts Virechaka Yoga by specifying all 
these Dosha through Virechana Karma. 
The clinical study 
 This study was carried out on 30 subjects having 
Tamaka Shwasa, among them 28 subjects completed the 
course of treatment other two left the treatment because 
of personal problems. For these 28 patients Virechana was 
administered in classical method.  
 At first Pachana was given with Panchakola 
Phanta to enhance the digestive power and also to 
facilitate the early digestion of Sneha. Snehapana was given 
with Kantakari Ghrita, which was administered in Arohana 
Matra depending upon the response of the patient till the 
appearance of Samyak Snigdha Lakshanaa. After this 3 
days’ gap was given and on 3rd day Virechana was 
administered with Trivrit Ashtaka Churna 30 gms, with the 
Madhu as Anupana. 
 The result of each therapy were statistically 
analysed and finally inferences were drawn on the basis of 
the data &some of them are put forward hereby. 
Deepana and Pachana: Among 28 patients of Madhyama 
koshta, 46.4 % patients got Niramam Lakshana on 2nd day 
and 25 % got Nirama Lakshana on 3rd day. This may be 
due to drug Panchakola Phanta of 30 ml thrice a day is 
sufficient to produce Nirama Lakshanas in Madhyama 
Koshta person.  
Samyak Snigdha Lakshana: It can be divided into two viz. 
Koshta related Lakshana, and Tvacha related Lakshana. 
The symptoms related to Koshta such as Vatanulomana, 
Deepta Agni, Varcha Snigdhata, Asamhata Varcha appeared 
on 3-4 days in 89.3 % patients. The symptoms related to 
skin such as Mriduta and Snigdhata of Tvacha appeared on 
4-5 days in 71.4 % patients. 
 Overall Samyak Snigdha Lakshanas appeared more 
earlier in females than in males i.e. it appeared on 3rd day 
itself in females whereas it was noticed in males on 4th 
and 5th day. 
Palatability of Virechana Yoga: 100% palatability was 
found in all 28 patients as the Yoga contains Trijataka, 
Sarkara also the Yoga is administered with Honey as 
Anupana this makes Yoga more palatable to the patients. 
Onset of 1st Virechana Vega (Latency Period): 64% of 
patients got 1st Vega within 30 minutes, as the Vega starts 
during Pachyamana Avastha of Aushada, as the state of 
Agni was good after Snehapana so that maximum number 
patients got 1st Vega in 30 minutes. 
Also the Trivrt Ashtaka Churna is having approximately of 
85% Laghu Ruksha Gunas, 90% of Katu Tikta Rasas, 70% of 
Ushna Virya, 50% of Katu Vipaka, from these properties of 
Trivrt Ashtaka Churna onset of 1st Vega occurred within 
30 minutes. 
Total duration of Virechana Karma: Maximum number 
of the patients i.e. 46.4 % patients got completed in 7 
hours 30 minutes to 9 hours, 39.3 % patients got 
completed within 5 hours to 7 hours 30 minutes, 14.3 % 
patients got completed in 9 - 12 hours. 
Total number of Virechana Vega’s: Maximum of 57.1 % 
patients got 15 - 19 Vegas, 7.4% patients got more than 23 
Vegas and 35.7 % patients got 10-14 Vegas. 
Vegiki Shuddhi: Maximum of 89.3 % patients got 
Madhyama Vegeki Shuddhi (10-20 Vegas) and minimum of 
3.6 % patient had Avara Vegiki Shuddhi (Upto 10 Vegas), 
remaining 7.1 % got Pravara Vegiki Shuddhi (21-30 Vegas). 
Antaki Shuddhi: Maximum of 57.1 % patients got Pittanta 
that means in Madhyama Matra of Trivrt Ashtaka Churna 
i.e. 30 gms with Madhu as a Anupana, can able produce 
Pittanta in Mrudu Koshta individuals. 
Laingiki Shuddhi: Only Karshyata, Hridhvarna Shuddhi 
were absent in 76 % patients and Dourbalyata was absent 
in 28.8 % patients. Remaining all Lakshana were present in 
maximum percentage of patients (approx. >75%). 
Samsarjana Krama: 92.9 % of patients followed 
Madhyama Shuddhi Krama of Samsarjana Krama with 3 
Anna Kala per day for 5 days 
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The effect of therapy 
On Subjective Parameters of Tamaka Shwasa 
 All subjective parameters found statistically 
significant improvement at the level of P< 0.001 (by 
Friedman test and post hoc Wilcoxson test analysis). This 
shows the effect Virechana by Trivrt Ashtaka Churna in 
Tamaka Shwasa. 
Shwasakruchrata and its duration: The Dusta Kapha 
obstructs the Prakupita Vayu in Pranavaha Srotas & this 
obstruction is relieved better by Virechana Karmaas it 
does the Vatanulomana, Kapha Dosha is pacified by Ushna, 
Tikshana Guna & Katu, Tikta Rasa of Haritaki, Trikatu and 
Trivrt. The Pitta Sthana Shudhi is done by Virechana & 
pacified by Snigdha, Shita Guna of Sharkara (6parts). 
Kasa: Due to Tridosa-hara, Ushnavirya, Kasashwasahara 
properties of Trivrt TrikatuTrijataka Vidanga etc drugs & 
Sroto-rodha of the Pranavaha Srotas is cleared, Kasa was 
reduced statistically. 
Ghurghurakam: It is produced due to obstruction of 
Prana Vayu& this is relieved better by Virechana Karma 
due to its effect on Srotorodha, & Vatanulomaka & also 
Kapha Pitta Shodhaka. 
Asinolabhatesaukhyam: Due to Pitta Sthana Dushti, there 
is Ama Rasautpatti & this causes excess secretion of Dusta 
Kapha in Pranvaha Srotas. When Vayu gets obstructed by 
Dusta Kapha, on lying the Vayu get entrapped and unable 
to escape, and secondly at this stage there is decrease the 
space for the movement of Prana Vayu. The Virechana 
Karma by its effect does the Shuddhi of Pitta Sthana, 
Vatanulomaka & also does Kapha Pitta Shodhana. 
Kaphanisteevana: Shodhan Chikitsa has better results as 
Snehapana (with Kantakari Ghrita) helps in easy removal 
of sticky & thick sputum. Srotosodhana by Virechana helps 
in removal of Dusta Kapha & facilitates the movement of 
Pranvayu. By this patient feels relaxed after spitting out 
the sputum in every time. 
Objective Parameters of Tamaka Shwasa 
 Majority of objective parameters found 
statistically significant improvement at the level of P< 
0.001 (by Friedman test and post hoc Wilcoxson test 
analysis also by paired T test), except in parameters like 
Crepitation and FEV1%. 
Auscultation: It was done throughout the process of 
treatment and found statistically significant results in 
Breath-sounds, Wheeze and Ronchi, as because these 
abnormal sounds got treated efficiently by Snehana-
Swedana, followed by Virechana. But non-significant in 
Crepitation sounds as it was found only in 14.3 % patients 
so it’s not possible more on it.  
Spirometry Analysis: There was significant increase in 
FVC and FEV, suggests that there is significant increase in 
forced vital capacity and lung capacity also significant 
increase in forced expiratory capacity (Friedman and post 
hoc Wilcoxson Tests).  
Respiratory rate: Before treatment and after Samsarjana 
karma rate of Respiration found statistically increased 
(paired T test).  
 Suggests significant reduction in airway 
obstruction due to broncho constriction, airway edema, 
sticky lodged mucous plug and inflammation, by the 
Virechana Karma with Trivrt Ashtaka Churna. 
Subjective Parameters of Virechana 
Samyaka Yoga Lakshana: 89% of patients got Samyak 
Virikta Lakshanas. Among them Karshyata, Hridhvarna 
Shuddhi was absent in 20 patients and Daurbalyata was 
absent in 8 patients. However, on Cochran’s Q test analysis 
where Q=159.84 and p < 0.001 found significant results in 
Samyak Virikta Lakshanas, this shows that 30 gms of Trivrt 
Ashtaka Churna can produce Samyaka Yoga Lakshana in 
Mrudhu Koshta individuals. 
Ayoga Lakshana: Among Virechana Ayoga Lakshanas 
Chardi in 16 patients and Tandra in 5 patients were 
observed and further these symptoms were subsided by 
itself.  
Atiyoga Lakshana: In this study no one complained of 
adverse effects or any type of complications during the 
Virechana Karma, this suggests that 30 gms of Trivrt 
Ashtaka Churna as a Virechaka Yoga will not lead Atiyoga 
Probable mode of action of drugs used for Virechana:  
 It is worth mentioning that Virechana Karma, 
unlike the modern purgatives, is not merely an act of 
evacuation of the bowel, but is a complete therapeutic 
measure that has systemic as well as local effects. 
 The drugs (Trivrt Ashtaka Churna) that are having 
properties like Ushna, Tikshna, Sukshma, Vyavayi, Vikasi 
and Adhobhagahara Prabhava, these drugs reach the 
Hridaya through their Swaveerya (Swaprabhava – 
Chakrapani) and circulates through large and small blood 
vessels of the body leading to the action of Virechana.  
Action of Ushna guna: Ushna Guna has Agneya property 
and hence Vishyandana occurs i.e. ‘Vilininan Kurvanti’ 
(Chakrapani). Hence it facilitates movement of morbid 
Doshas towards Koshta. 
Tikshna guna: “Tikshnyat Vicchindanti” Vicchindanti 
Chinnam Kuruvanti (Chakrapani), i.e. they break up the 
Doshas from larger to smaller molecules. 
Sheegrakarithwam Taikshnyam, Dalhana says that this 
helps in quick excretion. 
Sukshma: Sukshma Guna due to its Anupravanabhava, i.e. 
“Anuvathvam Pravanabhavacha, Anuvathvam-Anumargam 
Sancharithvam, Pravanthvamiha Koshta Gamanon-
mukatvam”. It will open micro channels and makes the 
Doshas to move towards Koshta. 
Vyavayi: Due to this, drugs spread quickly throughout the 
body and starts their action before its digestion. 
Vikasi: Vikasi drugs loosens and helps in breaking the 
binding of Dosha and Dushya (Dosha Dushya Samurchana 
Vighatanameva Chikitsa). From all these properties Doshas 
are driven to Koshta. The presence of Pritvi and Ap 
Mahabhutha Pradhanyata in Virechaka drug with the 
Adhobhaga Prabhava, eliminates the Doshas out through 
Guda Marga. 
 It can be summarized as the drug which is 
administered even before it passes through the second 
phase of digestion due to Vyavayi quality, circulates all 
over the body through minute channels with the help of 
Anuthwa of Sukshma Guna. Thus traveled medicinal 
properties breaks the binding of Dosha and Dushya in the 
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site of Vyadhi manifestation with the help of Vikasi Guna. 
By Ushna Tikshna property they get liquefied and moves 
towards Koshta by Pravana Bhava of Sukshma Guna. This is 
possible when Vata is under control by means of Snehana 
and Swedana in the Poorvakarma. Later the Dosha which is 
reached to the Koshta is eliminated by the Prabhava 
(Adhobagahara Prabhava) of Virechana Dravyas. 
Systemic action: Doshas are brought to Koshta from 
Snehana and Swedana, from there they are eliminated by 
Virechana which suggests action throughout the body. 
 Oleation (Snehana) and Sudation (Swedana) prior 
to Virechana helps in dissolving the intracellular toxins 
and expel them into exterior of cell from where they are 
thrown outside the body. Scientific explanation for this 
whole procedure can be summarized as: 
1. Passive diffusion is the most important mechanism for 
majority of drug transport. Lipid soluble drugs diffuse 
by dissolving in the lipoidal matrix of the membrane, 
the rate of transport being proportional to lipid: water 
partition coefficient of the drug. A more lipid soluble 
drug attains higher concentration in the membrane 
and diffuses quickly. 
2. As temperatures increases, (externally by sudation) 
both the cell membrane and the proteins can be 
affected. The fatty acid tails of the phospholipid bilayer 
can "melt" at high temperatures meaning that they 
become more fluid and allow more movement. This 
affects the permeability of the cell which increases. 
3. Heat is expected to enhance the body fluid circulation, 
blood vessel wall permeability, rate-limiting 
membrane permeability, and drug solubility. Heating 
the skin after the topical application of a drug will 
increase drug absorption into the vascular network, 
enhancing the systemic delivery but decreasing the 
local delivery as the drug molecules are carried away 
from the local delivery site studies indicate that 
temperature changes of approximately 5°C are 
necessary to cause measurable changes in cell 
membrane permeability. 
4. External heating induces changes in hemodynamic, 
body fluid volume, and blood flow distribution, which 
in turn may affect the pharmacokinetics or 
bioavailability of administered drug. The body's initial 
response to heat is peripheral vasodilation followed 
by perspiration, which results in a large fraction of the 
total blood volume being circulated through the skin 
vessels for cooling.  
Local action: Locally mild inflammation occurs which is 
transient due to UshnaTikshna property and drugs which 
irritates the intestinal mucosa. Hence Hyperemia results 
due to arteriolar and capillary dilatation and also 
exudation of protein substances which helps in dilution of 
toxins. 
These Dosha which is reached to the Koshta is eliminated 
by the Prabhava (Adhobagahara Prabhava) of Virechana 
Dravyas. 
CONCLUSION 
 Virechana Karma is mentioned in Tamaka Shwasa 
as Ubhaya Pratyanika Chikitsa as it acts on both Moola 
Sthana of Dosha i.e. Pitta and other associated Doshas i.e. 
Kapha and Vata. All the general Nidana’s mentioned for 
Shwasa Roga even holds good for Tamaka Shwasa also.  
 Maximum patients ended up with Madhyama Shuddhi 
89% and Pittanta Virechana 57.1%. Clinical signs & 
symptoms of Tamaka Shwasa improved after treatment. In 
that also Shwasakrichrata, Cough, Ghurghuraka, Breath 
sounds Wheeze and Respiratory rate shown statistically 
highly significant results Samsarjana Krama. Spirometry 
analysis also shown significant results in FVC and FEV1 at 
P>0.001. 
 Thus Virechana Karma is effective on signs and 
symptoms of Tamaka Shwasa. Hence it can be concluded 
that the trail drug Trivrt Ashtaka Churna acts a Virechaka 
Yoga in the Management of Tamaka Shwasa effectively. 
The Observations 
 The assessment of each patient is done on various 
parameters like clinical signs and symptoms at B.T. (Before 
treatment) A.Sn. (After Snehapana), A.V. (After Virechana ) 
& A.Sm. (After Samsarjana), Laboratory investigations 
assisted radiologically, and other parameter like 
Spirometric Analysis was carried out B.T and A.Sm.  
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